News
* Readers are advised that the press releases and other information posted on this site are current only on their original publication date. Please note that such press releases and other information may now be outdated or rendered inaccurate due to passage of time or subsequent material changes in facts and circumstance.
2021
- Dec 22, 2021 Products & Services・Company・IR・Sustainability Rated 3.5 stars in The 3rd Nikkei SDGs Management Survey
- Dec 22, 2021 Products & Services・Company・IR・Sustainability Rated 3 stars in the 5th Nikkei Smart Work Management Survey
- Dec 22, 2021 IR Notice Regarding Selection of Prime Market in Tokyo Stock Exchange New Market Segments
- Dec 22, 2021 IR Notice of Transition to a Company with Audit ＆ Supervisory Committee
- Nov 25, 2021 IR Financial Results Briefing for 2nd Quarter FY2021 (Abridged version)
- Nov 11, 2021 IR Consolidated Financial Results for the Six Months Ended September 30, 2021
- Nov 11, 2021 IR Notice Concerning Revisions to Consolidated Financial Results Forecasts for the Six Months Ended September 30, 2021
- Oct 1, 2021 Company Announcement of Official LinkedIn Account
- Sep 10, 2021 Company Regarding the Recent Novel Coronavirus Infection at an ESPEC Subsidiary
- Aug 31, 2021 IR Financial Results Briefing for 1st Quarter FY2021 (Abridged version)
- Aug 30, 2021 Company Regarding the Recent Novel Coronavirus Infection at ESPEC
- Aug 25, 2021 Company Regarding the Recent Novel Coronavirus Infection at ESPEC
- Aug 20, 2021 Company Regarding the Recent Novel Coronavirus Infection at ESPEC and its Subsidiary
- Aug 6, 2021 IR Consolidated Financial Results for the Three Months Ended June 30, 2021
- Aug 4, 2021 Company Countermeasures Against and the Status of the Spreading of the Coronavirus Disease (COVID-19)（Updated on: Aug. 4, 2021）
- Jul 29, 2021 Company Regarding the Recent Novel Coronavirus Infection at ESPEC
- Jul 14, 2021 IR Corporate Governance Report
- Jul 14, 2021 IR Notice Concerning Results and Completion of Acquisition of Own Shares Through Off-Auction Own Share Repurchase Trading System (ToSTNeT-3)
- Jul 14, 2021 IR Notice Concerning Acquisition of Own Shares and Repurchase of Own Shares Through Off-Auction Own Share Repurchase Trading System (ToSTNeT-3)
- Jun 25, 2021 Company Countermeasures Against and the Status of the Spreading of the Coronavirus Disease (COVID-19)（Updated on: Jun. 25, 2021）
- Jun 7, 2021 IR Financial Results Briefing for FY2020 (Abridged version)
- May 26, 2021 IR Notice of Revision of Basic Policy on Establishing Internal Control System
- May 25, 2021 IR NOTICE OF THE 68TH ORDINARY GENERAL MEETING OF SHAREHOLDERS
- May 24, 2021 IR Notice of Differences between Consolidated Financial Forecast Figures and Financial Results for Fiscal 2020 and Resolution of Dividend of Surplus
- May 24, 2021 IR Consolidated Financial Results for the Fiscal Year Ended March 31, 2021
- Apr 28, 2021 Company Countermeasures Against and the Status of the Spreading of the Coronavirus Disease (COVID-19)（Updated on: Apr. 28, 2021）
- Apr 7, 2021 Company Countermeasures Against and the Status of the Spreading of the Coronavirus Disease (COVID-19)（Updated on: Apr. 7, 2021）
- Mar 25, 2021 Company Countermeasures Against and the Status of the Spreading of the Coronavirus Disease (COVID-19)（Updated on: Mar. 25, 2021）
- Mar 4, 2021 IR Financial Results Briefing for 3rd Quarter FY2020 (Abridged version)
- Feb 18, 2021 IR Summary of Financial Results (Consolidated) for the Third Quarter of Fiscal 2020 Ending March 31, 2021
- Feb 18, 2021 IR Notice of Revisions of Consolidated Full-Year Financial Forecast and Year-End Dividend Forecast for Fiscal 2020
- Feb 9, 2021 Company Regarding the Recent Novel Coronavirus Infection at ESPEC
- Feb 9, 2021 Company Countermeasures Against and the Status of the Spreading of the Coronavirus Disease (COVID-19)（Updated on: Feb. 9, 2021）
- Jan 25, 2021 Company Regarding the Recent Novel Coronavirus Infection at ESPEC
- Jan 25, 2021 Company Countermeasures Against and the Status of the Spreading of the Coronavirus Disease (COVID-19)（Updated on: Jan. 25, 2021）
- Jan 14, 2021 Company Regarding the Recent Novel Coronavirus Infection at ESPEC
- Jan 14, 2021 Company Countermeasures Against and the Status of the Spreading of the Coronavirus Disease (COVID-19)（Updated on: Jan. 14, 2021）
- Jan 7, 2021 Company Countermeasures Against and the Status of the Spreading of the Coronavirus Disease (COVID-19)（Updated on: Jan. 7, 2021）